Home Biosimilar Antibodies Immunology & Inflammation IL Receptor Anrukinzumab (Anti-IL-13) For research use only.
Not for use in humans.

Anrukinzumab (Anti-IL-13)

Synonyms: IMA-638

Anrukinzumab (Anti-IL-13) is a humanized monoclonal antibody targeting IL-13. It reduces lung inflammation and can be used in studies of ulcerative colitis (UC) as well as asthma. MW :150 KD.

Anrukinzumab (Anti-IL-13)

Purity & Quality Control

≥99

Choose Selective IL Receptor Inhibitors

Biological Activity

Description Anrukinzumab (Anti-IL-13) is a humanized monoclonal antibody targeting IL-13. It reduces lung inflammation and can be used in studies of ulcerative colitis (UC) as well as asthma. MW :150 KD.

Product Details

CAS No. 910649-32-0
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Anrukinzumab (Anti-IL-13) | Anrukinzumab (Anti-IL-13) supplier | purchase Anrukinzumab (Anti-IL-13) | Anrukinzumab (Anti-IL-13) cost | Anrukinzumab (Anti-IL-13) manufacturer | order Anrukinzumab (Anti-IL-13) | Anrukinzumab (Anti-IL-13) distributor